BACKGROUND
Changes in gait patterns can be used in the diagnosis and monitoring of many orthopedic and sports-related disorders and neurological conditions (cerebral palsy and diabetic foot neuropathy), and even as an indication of an increased risk of falling in the elderly. Current gait tests, however, require lengthy procedures that can only be performed in dedicated gait labs with complex and expensive equipment. As a result, the tremendous potential of gait analysis in orthopedics, neurology, sports medicine, and other areas has limited use in daily practice.
THE SENSOGO SYSTEM
Sensors: Matchbox-sized sensors measure 3D acceleration, 3D rotational velocity, and absolute direction of movement
Analysis: Proprietary algorithms compute key gait parameters, including single-limb support (SLS), double-limb support (DLS), velocity, cadence, stride size, and trends in knee joint range of motion
Data report: Doctor receives a report with patient history and easy-to-read graphs tailored for each application
THE SENSOGO 5-POINT GAIT ANALYSIS
1. Strap sensors onto each leg (disposable straps)
2. Patient walks naturally for several minutes (in or outside doctor’s office)
3. Sensors transmit data to the SensoGo Clinic Server
4. SensoGo Analysis Server analyzes data
5. Report is sent directly to doctor within minutes
THE ADVANTAGES
SensoGo’s platform technology offers a new paradigm in gait analysis -
• Simple operation, no need for technical expertise
• Easy-to-use anywhere: clinic, sports field, home, rehab, study setting
• Results almost immediately
• Data from natural walking without cameras or gait mat
• No hassle for patient, completely wireless
• No capital costs for clinic
THE MARKET
SensoGo’s first target is osteoarthritis (OA) of the knee. With an estimated 22 million doctor visits associated with knee OA, SensoGo’s potential for this one application exceeds $600 million annually in the United States alone. Other applications SensoGo is exploring include diabetic foot neuropathy, neurological disorders, sports medicine, and fall prevention. The Company estimates its potential from OA (knee) and diabetic foot alone at around $2 billion. Additional applications increase the SensoGo opportunity significantly.
Gait lab equipment used today — cameras, software ($100,000), and gait mats ($30,000) — is typically found at larger medical centers. Some insoles, shoes with sensors, and portable sensor systems are in the market and focus on home use. SensoGo is the first to offer a comprehensive, yet convenient and affordable gait analysis system for widespread use in the medical arena.
Contact
Development Stage
Technology development
Founded: Aug 2011
Investor: The Trendlines Group
Key Personnel
Tal Anker, Ph.D., CEO, CTO
Former CTO and director of system and software architecture, Marvell Software Solutions, Israel; extensive research background; holds several patents in network security, distributed systems / algorithms, networking, and real-time operating systems
Dr. Ronen Debi, Director,
Medical Scientist
Leading researcher in gait analysis; head, Department of Orthopedics, Barzilai Hospital; specialist in joint replacement and sport medicine surgeries; holds a patent in the field of hip implants
Prof. Danny Dolev, Director,
Chief Scientist
World leader in the areas of distributed computing, fault tolerant systems, and sensor networks; former director, Inventech (Israeli VC investment company); consultant to high-tech and start-up companies